{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:13:40Z","timestamp":1782990820613,"version":"3.54.5"},"reference-count":176,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.tips.2016.08.001","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T17:31:33Z","timestamp":1473874293000},"page":"945-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy"],"prefix":"10.1016","volume":"37","author":[{"given":"Mikhail","family":"Romashko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schragenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2016.08.001_bib1505","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib1510","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbagen.2012.02.010","article-title":"High glucose-induced Ca2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and independent pathways","volume":"1820","author":"Kumar","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.tips.2016.08.001_bib1515","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2016.08.001_bib1520","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2015.09.003","article-title":"Translational significance of heme oxygenase in obesity and metabolic syndrome","volume":"37","author":"Abraham","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib1525","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2016.08.001_bib1530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ki.1990.13","article-title":"Cytochrome P450-dependent arachidonic acid metabolism in human kidney","volume":"37","author":"Schwartzman","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.tips.2016.08.001_bib1535","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2016.08.001_bib1540","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prostaglandins.2015.01.002","article-title":"Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway","volume":"116-117","author":"Cao","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1545","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1550","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.109.157545","article-title":"Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice","volume":"331","author":"Sodhi","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2016.08.001_bib1555","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/en.2012-2166","article-title":"Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice","volume":"154","author":"Ma","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2016.08.001_bib1560","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.tips.2016.08.001_bib1565","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.abb.2004.10.009","article-title":"Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids","volume":"433","author":"Spiecker","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tips.2016.08.001_bib0885","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1517\/17425255.4.2.165","article-title":"Eicosanoids and renal damage in cardiometabolic syndrome","volume":"4","author":"Imig","year":"2008","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.tips.2016.08.001_bib1570","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/scd.2010.0098","article-title":"Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPAR\u03b3","volume":"19","author":"Kim","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.tips.2016.08.001_bib1575","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prostaglandins.2011.12.004","article-title":"EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels","volume":"98","author":"Sodhi","year":"2012","journal-title":"Prost. Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1580","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000154819","article-title":"The biological significance and physiological role of heme oxygenase","volume":"6","author":"Abraham","year":"1996","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.tips.2016.08.001_bib1585","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/oxfordjournals.jbchem.a124028","article-title":"Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation","volume":"113","author":"Shibahara","year":"1993","journal-title":"J. Biochem."},{"key":"10.1016\/j.tips.2016.08.001_bib1590","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1073\/pnas.90.20.9285","article-title":"Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage","volume":"90","author":"Balla","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2016.08.001_bib1595","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1681\/ASN.V261078","article-title":"Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats","volume":"2","author":"Martasek","year":"1991","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tips.2016.08.001_bib1600","doi-asserted-by":"crossref","first-page":"e0038","DOI":"10.5041\/RMMJ.10038","article-title":"Nitric oxide: the coming of the second messenger","volume":"2","author":"Murad","year":"2011","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.tips.2016.08.001_bib1605","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1751-7176.2008.06632.x","article-title":"Vascular system: role of nitric oxide in cardiovascular diseases","volume":"10","author":"Bian","year":"2008","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.tips.2016.08.001_bib1610","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.ATV.20.3.659","article-title":"Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells","volume":"20","author":"Dulak","year":"2000","journal-title":"Arterioscler Thromb Vasc. Biol."},{"key":"10.1016\/j.tips.2016.08.001_bib1615","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.prostaglandins.2015.04.004","article-title":"Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis","volume":"120","author":"Vanella","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1620","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/hy0102.100540","article-title":"Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency","volume":"39","author":"Vaziri","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib1625","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.1523-1755.1999.00670.x","article-title":"Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension","volume":"56","author":"Vaziri","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.tips.2016.08.001_bib1630","doi-asserted-by":"crossref","first-page":"H1999","DOI":"10.1152\/ajpheart.00082.2006","article-title":"Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase","volume":"291","author":"Sacerdoti","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1635","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prostaglandins.2006.07.001","article-title":"11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells","volume":"82","author":"Sacerdoti","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1640","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/db07-1764","article-title":"Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance","volume":"57","author":"Li","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2016.08.001_bib1645","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2011.07.005","article-title":"Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes","volume":"96","author":"Vanella","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1650","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/HYPERTENSIONAHA.108.124701","article-title":"Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats","volume":"53","author":"Nicolai","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib1655","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/scrt176","article-title":"Increased heme-oxygenase 1 expression decreases adipocyte differentiation and lipid accumulation in mesenchymal stem cells via upregulation of the canonical Wnt signaling cascade","volume":"4","author":"Vanella","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tips.2016.08.001_bib1660","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.febslet.2006.12.002","article-title":"Peg1\/Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner","volume":"581","author":"Kamei","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2016.08.001_bib1665","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00244.2004","article-title":"Mest\/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size","volume":"288","author":"Takahashi","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2016.08.001_bib1670","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1194\/jlr.M800046-JLR200","article-title":"L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice","volume":"49","author":"Peterson","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1675","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1194\/jlr.M800610-JLR200","article-title":"The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice","volume":"50","author":"Peterson","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2005.03.010","article-title":"Heme oxygenase and the cardiovascular-renal system","volume":"39","author":"Abraham","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2016.08.001_bib1685","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2004121082","article-title":"Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction","volume":"17","author":"Goodman","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tips.2016.08.001_bib1690","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1291\/hypres.30.341","article-title":"Reduced expression of heme oxygenase-1 in patients with coronary atherosclerosis","volume":"30","author":"Brydun","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1695","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18388\/abp.2005_3440","article-title":"Heme oxygenase-1 expression in disease states","volume":"52","author":"Deshane","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.tips.2016.08.001_bib1700","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.114.03884","article-title":"CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype","volume":"64","author":"Abraham","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib1705","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yjmcc.2006.11.020","article-title":"Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts","volume":"42","author":"Gross","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1710","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/FJC.0b013e318159cbe3","article-title":"Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning","volume":"50","author":"Gauthier","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1715","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1720","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the strong heart study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2016.08.001_bib1725","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-8703(89)90236-6","article-title":"Diabetic cardiomyopathy","volume":"118","author":"Zarich","year":"1989","journal-title":"Am. Heart J."},{"key":"10.1016\/j.tips.2016.08.001_bib0890","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(84)80207-7","article-title":"Clinically unrecognized ventricular dysfunction in young diabetic patients","volume":"4","author":"Mildenberger","year":"1984","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1730","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/0002-9149(94)90182-1","article-title":"Left ventricular systolic function in middle-aged patients with diabetes mellitus","volume":"73","author":"Mustonen","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1735","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00125-010-1718-8","article-title":"Association of glucose metabolism with diastolic function along the diabetic continuum","volume":"53","author":"Stahrenberg","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2016.08.001_bib1740","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1745","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.tips.2016.08.001_bib1750","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1755","first-page":"628","article-title":"Role of inflammation mediators in the pathogenesis of heart failure","volume":"2","author":"Boglioni","year":"2001","journal-title":"Ital. Heart J. Suppl."},{"key":"10.1016\/j.tips.2016.08.001_bib1760","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/ijms14022684","article-title":"Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction","volume":"14","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib0895","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2016.08.001_bib0900","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06826.x","article-title":"The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis","volume":"1281","author":"Padgett","year":"2013","journal-title":"Ann. N Y Acad Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib0905","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.2337\/db08-0079","article-title":"Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3","volume":"57","author":"Bugger","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2016.08.001_bib0910","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2016.08.001_bib0915","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.107.099499","article-title":"Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet","volume":"51","author":"Knight","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib0920","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/CS20090395","article-title":"Obesity is the major contributor to vascular dysfunction and inflammation in high fat diet hypertensive rats","volume":"118","author":"Elmarakby","year":"2010","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.tips.2016.08.001_bib0925","doi-asserted-by":"crossref","first-page":"F86","DOI":"10.1152\/ajprenal.00351.2009","article-title":"Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension","volume":"298","author":"Knight","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib0930","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCRESAHA.107.159129","article-title":"Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors","volume":"102","author":"Larsen","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib0935","doi-asserted-by":"crossref","first-page":"F965","DOI":"10.1152\/ajprenal.2000.279.6.F965","article-title":"Eicosanoid regulation of the renal vasculature","volume":"279","author":"Imig","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib0940","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.HYP.0000090123.55365.BA","article-title":"Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension","volume":"42","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib0945","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jcb.22486","article-title":"Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling","volume":"109","author":"Kusmic","year":"2010","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.tips.2016.08.001_bib0950","doi-asserted-by":"crossref","first-page":"H1020","DOI":"10.1152\/ajpheart.00465.2014","article-title":"Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice","volume":"308","author":"Roche","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib0955","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/jcb.23188","article-title":"Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice","volume":"112","author":"Vecoli","year":"2011","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.tips.2016.08.001_bib0960","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fphys.2012.00160","article-title":"Cobalt-protoporphyrin improves heart function by blunting oxidative stress and restoring NO synthase equilibrium in an animal model of experimental diabetes","volume":"3","author":"Cao","year":"2012","journal-title":"Front Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2011.10.002","article-title":"Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications","volume":"97","author":"Burgess","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib0970","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/ATVBAHA.111.241984","article-title":"Insulin resistance: metabolic mechanisms and consequences in the heart","volume":"32","author":"Abel","year":"2012","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2016.08.001_bib0975","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/oby.2009.343","article-title":"Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study","volume":"18","author":"Tadros","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.tips.2016.08.001_bib0980","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cardfail.2014.02.002","article-title":"High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial","volume":"20","author":"Kalogeropoulos","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.tips.2016.08.001_bib0985","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/sj.ijo.0801995","article-title":"Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans","volume":"26","author":"Williams","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.tips.2016.08.001_bib0990","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2174\/13816128113199990450","article-title":"Regenerative approaches to post-myocardial infarction heart failure","volume":"20","author":"Martin","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tips.2016.08.001_bib0995","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1556\/APhysiol.99.2012.4.1","article-title":"Overview of large animal myocardial infarction models (review)","volume":"99","author":"Lukacs","year":"2012","journal-title":"Acta Physiol. Hung."},{"key":"10.1016\/j.tips.2016.08.001_bib1000","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/HYPERTENSIONAHA.111.00495","article-title":"HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation","volume":"62","author":"Monu","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib1005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCRESAHA.111.243170","article-title":"Inflammation in myocardial diseases","volume":"110","author":"Marchant","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/erc.12.3","article-title":"Postinfarct cardiac remodeling and the substrate for sudden cardiac death: role of oxidative stress and myocardial fibrosis","volume":"10","author":"Sovari","year":"2012","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.tips.2016.08.001_bib1015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MAJ.0b013e318157388f","article-title":"Oxidative stress and cardiac repair\/remodeling following infarction","volume":"334","author":"Sun","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib1020","first-page":"92","article-title":"The constellation of hypertensive heart disease","volume":"49","author":"Pavlopoulos","year":"2008","journal-title":"Hellenic J. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1755-1536-6-11","article-title":"Neutrophil roles in left ventricular remodeling following myocardial infarction","volume":"6","author":"Ma","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.tips.2016.08.001_bib1030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12265-012-9398-z","article-title":"Extracellular matrix and fibroblast communication following myocardial infarction","volume":"5","author":"Ma","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1040","first-page":"1113","article-title":"Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling","volume":"466","author":"Ma","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tips.2016.08.001_bib1045","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI1830","article-title":"Protection from reoxygenation injury by inhibition of rac1","volume":"101","author":"Kim","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1089\/ars.2010.3375","article-title":"Mitochondrial injury and protection in ischemic pre- and postconditioning","volume":"14","author":"Di","year":"2011","journal-title":"Antioxid. Redox. Signal"},{"key":"10.1016\/j.tips.2016.08.001_bib1055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2010.06.058","article-title":"Oxidation of myofibrillar proteins in human heart failure","volume":"57","author":"Canton","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hlc.2004.02.008","article-title":"Role of oxidative stress in cardiac remodelling after myocardial infarction","volume":"13","author":"Grieve","year":"2004","journal-title":"Heart Lung. Circ."},{"key":"10.1016\/j.tips.2016.08.001_bib1065","first-page":"673","article-title":"Total and high molecular weight adiponectin levels in the rat model of post-myocardial infarction heart failure","volume":"66","author":"Kalisz","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.yjmcc.2011.11.015","article-title":"Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure","volume":"52","author":"Merabet","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2011.12.062","article-title":"Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction","volume":"167","author":"Kompa","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1080","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis","volume":"110","author":"Sirish","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.08.001_bib1085","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamcr.2011.01.014","article-title":"Mitochondrial dysfunction in diabetic cardiomyopathy","volume":"1813","author":"Duncan","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2016.08.001_bib1090","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diabetes.55.03.06.db05-1039","article-title":"Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy","volume":"55","author":"Shen","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2016.08.001_bib1095","doi-asserted-by":"crossref","first-page":"e885","DOI":"10.1038\/cddis.2013.418","article-title":"Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response","volume":"24","author":"Samokhvalov","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2016.08.001_bib1100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.yjmcc.2009.02.028","article-title":"Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells","volume":"46","author":"Katragadda","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","article-title":"Epoxyeicosatrienoic acids and cardioprotection: the road to translation","volume":"74","author":"Oni-Orisan","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor \u03b3 coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tips.2016.08.001_bib1115","doi-asserted-by":"crossref","first-page":"26597","DOI":"10.1074\/jbc.M301850200","article-title":"Bioenergetic analysis of peroxisome proliferator-activated receptor \u03b3 coactivators 1\u03b1 and 1\u03b2 (PGC-1\u03b1 and PGC-1\u03b2) in muscle cells","volume":"278","author":"St-Pierre","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","article-title":"PGC-1\u03b1 regulates the mitochondrial antioxidant defense system in vascular endothelial cells","volume":"66","author":"Valle","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1125","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1\u03b1 and mitochondrial metabolism - emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib1130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/ATVBAHA.109.198721","article-title":"Peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 overexpression prevents endothelial apoptosis by increasing ATP\/ADP translocase activity","volume":"30","author":"Won","year":"2010","journal-title":"Arterioscler Thromb Vasc. Biol."},{"key":"10.1016\/j.tips.2016.08.001_bib1135","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.108.784289","article-title":"Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction","volume":"118","author":"Schulz","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2016.08.001_bib1140","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","article-title":"Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus","volume":"291","author":"Meigs","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2016.08.001_bib1145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI116491","article-title":"Hypercholesterolemia increases endothelial superoxide anion production","volume":"91","author":"Ohara","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.08.001_bib1155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI10268","article-title":"Peroxisome proliferator-activated receptor \u03b3 coactivator-1 promotes cardiac mitochondrial biogenesis","volume":"106","author":"Lehman","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1160","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","article-title":"HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1\u03b1","volume":"451","author":"Arany","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.08.001_bib1165","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCRESAHA.110.223818","article-title":"PGC-1 coactivators in cardiac development and disease","volume":"107","author":"Rowe","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1170","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddi341","article-title":"Complete loss-of-function of the heart\/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy","volume":"14","author":"Palmieri","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2016.08.001_bib1175","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM199403313301308","article-title":"Inherited cardiomyopathies","volume":"330","author":"Kelly","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2016.08.001_bib1180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M","article-title":"Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy","volume":"49","author":"Loeffen","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2016.08.001_bib1185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10741-007-9079-1","article-title":"Mitochondrial centrality in heart failure","volume":"13","author":"Marin-Garcia","year":"2008","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.tips.2016.08.001_bib1190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/345489","article-title":"Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy","volume":"72","author":"Antonicka","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2016.08.001_bib1195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360091174169","article-title":"Inborn errors of mitochondrial fatty acid oxidation","volume":"37","author":"Bennett","year":"2000","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib1200","doi-asserted-by":"crossref","first-page":"10496","DOI":"10.1073\/pnas.92.23.10496","article-title":"Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood","volume":"92","author":"Strauss","year":"1995","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.08.001_bib1205","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1203\/00006450-198507000-00006","article-title":"Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia","volume":"19","author":"Hale","year":"1985","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1210","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI12590","article-title":"Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death","volume":"107","author":"Ibdah","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1203\/00006450-199012000-00023","article-title":"Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood","volume":"28","author":"Rocchiccioli","year":"1990","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.2003.045104","article-title":"Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles","volume":"551","author":"Garnier","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1225","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cvr\/cvn327","article-title":"TNF-\u03b1 reduces PGC-1\u03b1 expression through NF-\u03baB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model","volume":"81","author":"Palomer","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cmet.2007.06.005","article-title":"The nuclear receptor ERR\u03b1 is required for the bioenergetic and functional adaptation to cardiac pressure overload","volume":"6","author":"Huss","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2016.08.001_bib1235","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","article-title":"Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-\u03b3 coactivator 1\u03b1","volume":"103","author":"Arany","year":"2006","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.tips.2016.08.001_bib1240","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Transcriptional coactivator PGC-1\u03b1 controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2016.08.001_bib1245","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI9056","article-title":"Deactivation of peroxisome proliferator-activated receptor-\u03b1 during cardiac hypertrophic growth","volume":"105","author":"Barger","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1250","doi-asserted-by":"crossref","first-page":"H185","DOI":"10.1152\/ajpheart.00081.2008","article-title":"The transcriptional coactivator PGC-1\u03b1 is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis","volume":"295","author":"Lehman","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1\u03b1 null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.08.001_bib1260","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1073\/pnas.061035098","article-title":"Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1","volume":"98","author":"Michael","year":"2001","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.tips.2016.08.001_bib1265","doi-asserted-by":"crossref","first-page":"30843","DOI":"10.1074\/jbc.M303643200","article-title":"PGC-1\u03b2 in the regulation of hepatic glucose and energy metabolism","volume":"278","author":"Lin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1\u03b1 and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.08.001_bib1275","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"Finck","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2006.04.002","article-title":"Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation","volume":"3","author":"Uldry","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2016.08.001_bib1285","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","article-title":"Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1","volume":"100","author":"Patti","year":"2003","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.tips.2016.08.001_bib1290","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00125-006-0268-6","article-title":"PGC-1\u03b1: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes","volume":"49","author":"Soyal","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2016.08.001_bib1295","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bbamcr.2010.03.019","article-title":"Calcineurin signaling and PGC-1\u03b1 expression are suppressed during muscle atrophy due to diabetes","volume":"1803","author":"Roberts-Wilson","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2016.08.001_bib1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2016.07.004","article-title":"PGC-1\u03b1 regulates HO-1 expression, mitochondrial dynamics and biogenesis: role of epoxyeicosatrienoic acid","author":"Singh","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1305","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/scd.2016.0072","article-title":"Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1\u03b1 activation, which is required for HO-1 expression and increased mitochondrial function","volume":"25","author":"Waldman","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.tips.2016.08.001_bib1310","doi-asserted-by":"crossref","first-page":"H337","DOI":"10.1152\/ajpheart.00831.2001","article-title":"Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation","volume":"284","author":"Falck","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1315","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.phrs.2003.09.014","article-title":"14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries","volume":"49","author":"Gauthier","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2016.08.001_bib1320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.09.008","article-title":"Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation","volume":"83","author":"Dimitropoulou","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1325","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.bmcl.2003.08.060","article-title":"11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-\u03b1-induced VCAM-1 expression","volume":"13","author":"Falck","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2016.08.001_bib1330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10739680701456960","article-title":"Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels","volume":"15","author":"Imig","year":"2008","journal-title":"Microcirculation"},{"key":"10.1016\/j.tips.2016.08.001_bib1335","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/jpet.303.2.768","article-title":"Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels","volume":"303","author":"Ye","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2016.08.001_bib1340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2016.08.001_bib1345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1527-3466.2006.00169.x","article-title":"Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors","volume":"24","author":"Imig","year":"2006","journal-title":"Cardiovasc. Drug. Rev."},{"key":"10.1016\/j.tips.2016.08.001_bib1350","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/STROKEAHA.107.508325","article-title":"Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia","volume":"39","author":"Zhang","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.tips.2016.08.001_bib1355","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1360","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2353\/ajpath.2009.080544","article-title":"Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection","volume":"174","author":"Simpkins","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2016.08.001_bib1365","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS20110622","article-title":"Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension","volume":"122","author":"Neckar","year":"2012","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.tips.2016.08.001_bib1370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of \u03c9-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1375","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/FJC.0b013e3181c37d69","article-title":"Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury","volume":"55","author":"Chaudhary","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1380","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10038-003-0103-6","article-title":"Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred","volume":"49","author":"Sato","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.tips.2016.08.001_bib1385","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M806315200","article-title":"Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase","volume":"283","author":"EnayetAllah","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874073100701010001","article-title":"Novel role of soluble epoxide hydrolase in regulating cholesterol in mammalian cells","volume":"1","author":"Enayetallah","year":"2007","journal-title":"Open Drug Metab. J."},{"key":"10.1016\/j.tips.2016.08.001_bib1395","doi-asserted-by":"crossref","first-page":"e39165","DOI":"10.1371\/journal.pone.0039165","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2016.08.001_bib1400","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M113.458414","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue","volume":"288","author":"Bettaieb","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1405","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2016.08.001_bib1410","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: a potential target for metabolic diseases","volume":"8","author":"He","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tips.2016.08.001_bib1415","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00774-009-0134-y","article-title":"Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation","volume":"28","author":"Barbagallo","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.tips.2016.08.001_bib1420","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2009.10.012","article-title":"HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage","volume":"46","author":"Vanella","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.tips.2016.08.001_bib1425","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2016.08.001_bib1430","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbrc.2005.03.171","article-title":"Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients","volume":"331","author":"Ohtoshi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2016.08.001_bib1435","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/jm030514j","article-title":"Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility","volume":"47","author":"Kim","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1440","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1073\/pnas.96.16.8849","article-title":"Potent urea and carbamate inhibitors of soluble epoxide hydrolases","volume":"96","author":"Morisseau","year":"1999","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.tips.2016.08.001_bib1445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.pharmtox.45.120403.095920","article-title":"Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles","volume":"45","author":"Morisseau","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2016.08.001_bib1450","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1021\/bi050842g","article-title":"Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase","volume":"44","author":"Tran","year":"2005","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.tips.2016.08.001_bib1455","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib1460","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1021\/jm0500929","article-title":"Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility","volume":"48","author":"Kim","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1465","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/156802609788340805","article-title":"Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery","volume":"9","author":"Marino","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tips.2016.08.001_bib1470","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ps.1583","article-title":"Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical","volume":"64","author":"Morisseau","year":"2008","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.tips.2016.08.001_bib1475","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2016.08.001_bib1480","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2013.01.034","article-title":"Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients","volume":"227","author":"Schuck","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2016.08.001_bib1485","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.prostaglandins.2013.02.001","article-title":"In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor","volume":"104-105","author":"Podolin","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2016.08.001_bib1490","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bcp.12855","article-title":"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor","volume":"81","author":"Lazaar","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2016.08.001_bib1495","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI61398","article-title":"A mitochondrial bioenergetic etiology of disease","volume":"123","author":"Wallace","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.08.001_bib1500","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","article-title":"Mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association","volume":"118","author":"Murphy","year":"2016","journal-title":"Circ. Res."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614716301055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614716301055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T10:40:02Z","timestamp":1718793602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614716301055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":176,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0165614716301055"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2016.08.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}